RxSight, Inc. (RXST) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2020: $13.99M2021: $24.36M2022: $11.83M2023: $9.69M2024: $16.71M2025: $19.95M$19.95M
2020Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$19.95M+19.4%
2024$16.71M+72.4%
2023$9.69M-18.1%
2022$11.83M-51.4%
2021$24.36M+74.1%
2020$13.99M